Etude d'oligosaccharides bioactifs issus d'exopolysaccharides bactériens : obtention, caractérisation et relation structure/fonction

Titre alternatif
Producteur
Contributeur(s)
Éditeur(s) Paris 13
Identifiant documentaire 9-622
Identifiant OAI oai:archimer.ifremer.fr:622
Notice source
Auteur(s): Roger, Olivier
Mots clés Phosphorylation Sulphation Depolymerization NMR spectroscopy Structure Deep sea hydrothermal vent Bacteria Exopolysaccharides Activité anticoagulante Phosphatation Sulfatation Dépolymérisation Spectroscopie de RMN Structure Sources hydrothermales Bactéries Exopolysaccharides
Date de publication 29/11/2002
Date de création
Date de modification
Date d'acceptation du document
Date de dépôt légal
Langue fre
Thème
Type de ressource
Source
Droits de réutilisation info:eu-repo/semantics/openAccess

Région

Département

Commune

Description
Unusual exopolysaccharides (EPS) produced by heterotrophic aerobic and mesophilic bacteria originating from hydrothermal vent, were reviewed as a new source of polysaccharidic structures endowed with innovative biological properties. The first step of this study was the structure determination of the EPS GY785, synthesized by Alteromonas infernus. A highly branched nonasaccharidic repetitive unit was identified using chemical modifications and nuclear magnetic resonance spectroscopy. This 106 g/mol polysaccharide is composed of glucose, galactose, glucuronic acid, galacturonic acid, and contains a single branched ramification and one sulphate group. The second step was the preparation of low molecular weight bioactive polysaccharides presenting interest in the treatment of diseases. Three chemically modified EPS (GY785, HE800, and HYD721) were prepared using free radical depolymerization, sulphation and phosphation. Physicochemical studies of those homogeneous derivatives showed that sulphate contents modulate the anticoagulant activity. Preliminary studies of a highly sulphated fraction of low molecular weight EPS GY785 showed a high affinity for antithrombin with a less in vitro anticoagulant activity than heparin. Marine exopolysaccharides are a great source of molecules endowed with biotechnological interest but a perfect knowledge of structureactivity relationships is essential before the conception of drugs.

0

Consultations

0

Téléchargements